Incyte Corporation (($CC:INCY.CUR)) announced an update on their ongoing clinical study. Incyte Corporation recently completed a Phase 2 clinical ...

Incyte Corporation (($CC:INCY.CUR)) announced an update on their ongoing clinical study. Incyte Corporation recently completed a clinical study ...

Lebowitz covers the Healthcare sector, focusing on stocks such as Incyte, Alnylam Pharma, and Cogent Biosciences. In addition to Citi, Pliant Therapeutics also received a Hold from Oppenheimer’s Jeff ...

DelveInsight's Uveal Melanoma Market Insights report includes a comprehensive understanding of current treatment practices, ...

Discover the challenges and opportunities for Keros Therapeutics, Inc., including FDA designations, partnerships, and ...

US stocks posted moderate declines on Thursday as underwhelming results from economic bellwether Walmart hit sentiment, while ...

As of 1520 BST, the Dow Jones Industrial Average was down 0.66% at 44,641.85, while the S&P 500 shed 0.39% to 6,370.86 and the Nasdaq Composite came out of the gate 0.27% weaker at 21,114.68.

The market offers significant opportunities driven by increasing demand for personalized therapies, especially in oncology and rare diseases. Targete ...

Today, Governor Matt Meyer announced thirteen new appointments to the Delaware Prosperity Partnership Board following its ...